Skip to main content

Table 1 Demographic and clinical characteristics of study patients

From: Earlobe arterialized capillary blood gas analysis in the intensive care unit: a pilot study

Patients 55
  Male 40 (72.7%)
  Age in years 63 (24 to 83)
  Arterial hypertension 23 (41.8%)
  Diabetes mellitus 19 (34.5%)
  Chronic cardiac failure 4 (7.3%)
  Severe vasculopathy 4 (7.3%)
  Renal insufficiency 5 (9.1%)
Diagnostic at ICU admission  
  Severe sepsisa 21 (38.1%)
  Respiratory failure 7 (12.7%)
  Severe trauma 7 (12.7%)
  Neurological 6 (10.8%)
Cardiogenic shock 5 (9.1%)
  Miscellaneous 9 (16%)
Clinical variables  
  PEEP (cmH2O) 7.1 (4 to 12)
  FiO2 0.36 (0.21 to 0.66)
  Minute volume (L/min) 9 (5.5 to 19)
  APACHE II 18.3 (3 to 34)
  Mean arterial pressure (mmHg) 80 (57 to 113)
  Cardiac index (L/min/m2) 3.2 (1 to 5.9)
  Arterial lactate (mg/dl) 18.7 (6 to 71)
  Arterial lactate > 22 mg/dl 10 (18%)
  Sepsisa 32 (58.2%)
  Platelets (× 103/dl) 226 (54 to 669)
  Prothrombin time (ratio) 1.2 (1 to 1.9)
  Prophylactic anticoagulant 40 (72.7%)
  Antiplatelet treatment 6 (10.9%)
  Vasoactive treatment 36 (65.5%)
  NE 30 (83.3%)
  NE dose (μg/kg/min) 0.49 (0.02 to 3.02)
  Other vasoconstriction treatment 3 (8.2%)
  Inotropic treatment 5 (13.8%)
  Vasodilation treatment 2 (5.5%)
  1. Data reported as mean (range), except where% is shown in which case values illustrate ‘incidence’. APACHE II, Acute Physiology and Chronic Health Evaluation II score; NE, norepinephrine; PEEP, positive end expiratory pressure.
  2. aFollowing Surviving Sepsis Campaign Guidelines [17].